Back

Clinical benefits of high dose statins according to the atherothrombotic risk stratification after acute myocardial infarction. The FAST-MI registries.

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Acute coronary syndromes, coronary artery disease: treatment Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Etienne Puymirat

European Hospital Georges Pompidou, Paris (France)

16 More presentations in this session

Presentation thumbnail
Doctor K. Svendsen (Oslo, NO)
Abstract Slides
Presentation thumbnail
Doctor R. CHEN (Beijing, CN)
Abstract Slides
Presentation thumbnail
Associate Professor K. Dyrbus (Zabrze, PL)
Abstract Slides
Presentation thumbnail
Doctor A. Mahabadi (Essen, DE)
Abstract
Presentation thumbnail
Doctor C. Kissel (Zurich, CH)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Acute coronary syndromes, coronary artery disease: treatment

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Real-world use of rosuvastatin 40 mg and ezetimibe 10 mg after ACS: is this combination effective in achieving guideline-recommended LDL-C goals after discharge?
20 March 2026
thumbnail
Congress Presentation
CT-based cardiovascular risk stratification benefits in asymptomatic patients
9 May 2021
thumbnail
Congress Presentation
Efficacy and safety of rapid up-titration of medical therapies for heart failure by ischemic and non-ischemic etiologies: an analysis of STRONG-HF
1 September 2025
thumbnail
Congress Presentation
Effect of risk enhancers versus technical aspects of high thrombotic risk criteria on adverse clinical events after PCI: insights from 2020 ESC NSTE-ACS Guidelines
28 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources